UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008055
Receipt number R000009487
Scientific Title Sub-study on genetic markers responsible to effects of HMG-CoA reductase inhibitor preventing recurrence of stroke
Date of disclosure of the study information 2012/06/01
Last modified on 2023/06/08 10:07:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Sub-study on genetic markers responsible to effects of HMG-CoA reductase inhibitor preventing recurrence of stroke

Acronym

J-STARS Genomics

Scientific Title

Sub-study on genetic markers responsible to effects of HMG-CoA reductase inhibitor preventing recurrence of stroke

Scientific Title:Acronym

J-STARS Genomics

Region

Japan


Condition

Condition

Ischemic stroke

Classification by specialty

Neurology Neurosurgery

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

The objective of this study is to clarify the genetic markers responsible to the recurrence of stroke and cognitive impairment in order to establish diagnosis and treatment for patients with stroke

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

Genetic markers responsible to the high risk of stroke recurrence , efficacy of HMG-CoA inhibitor, and appearance of cognitive impairment

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

45 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

(1)The enrolled subjects in JSTARS study
(2)The subjects from whom the informed consent was obtained

Key exclusion criteria

none

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Masayasu
Middle name
Last name Matsumoto

Organization

Hiroshima University Graduate School of Biomedical and Health Sciences

Division name

Department of Clinical Neuroscience and Therapeutics

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima

TEL

082-257-5201

Email

naika3@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Tomohisa
Middle name
Last name Nezu

Organization

Hiroshima University Graduate School of Biomedical Sciences

Division name

Department of Clinical Neuroscience and Therapeutics

Zip code

734-8551

Address

1-2-3 kasumi, Minami-ku, Hiroshima 734-8551, Japan

TEL

082-257-5201

Homepage URL

http://jstars.umin.ne.jp

Email

naika3@hiroshima-u.ac.jp


Sponsor or person

Institute

Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences

Institute

Department

Personal name



Funding Source

Organization

Translational Research Center for Medical Innovation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor

signpost corporation

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hiroshima University Medical Policy Office

Address

1-2-3 Kasumi, Minami-ku, Hiroshima

Tel

082-257-5555

Email

iryo-seisaku@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2010 Year 03 Month 14 Day

Date of IRB

2010 Year 05 Month 10 Day

Anticipated trial start date

2010 Year 05 Month 01 Day

Last follow-up date

2013 Year 10 Month 31 Day

Date of closure to data entry

2013 Year 10 Month 31 Day

Date trial data considered complete

2014 Year 03 Month 01 Day

Date analysis concluded

2024 Year 03 Month 31 Day


Other

Other related information

Recurrence of Stroke
Dementia


Management information

Registered date

2012 Year 05 Month 30 Day

Last modified on

2023 Year 06 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009487


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name